LM-CD45: Began Phase II U.S. trial

Cantab Pharmaceuticals plc (CNTBY), U.K. Product: LM-CD45, a pair of monoclonal antibodies that destroy passenger leukocytes in the donor kidney Indication: Prevent rejection of kidney transplants Sta...